LawPlayer
My bookmarksSign up freeSign up free
Source

Commission Delegated Regulation (EU) 2020/217 of 4 October 2019 amending, for the purposes of its adaptation to technical and scientific progress, Regulation (EC) No 1272/2008 of the European Parliament and of the Council on classification, labelling and packaging of substances and mixtures and correcting that Regulation (Text with EEA relevance)

Commission Delegated Regulation (EU) 2020/217 of 4 October 2019 amending, for the purposes of its adaptation to technical and scientific progress, Regulation (EC) No 1272/2008 of the European Parliament and of the Council on classification, labelling and packaging of substances and mixtures and correcting that Regulation (Text with EEA relevance)

Delegated Regulation (EU) 2020/217 · Regulation · 5 articles

In forceLast amended 2025-08-01

Version history

  1. Superseded version
  2. In force

Data as of 2026-11-02 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Amendments to Regulation (EC) No 1272/2008

Article 1

Open ↗

Regulation (EC) No 1272/2008 is amended as follows: (1)  Annex II is amended as set out in Annex I to this Regulation; (2)  Annex III is amended as set out in Annex II to this Regulation; (3)  Annex VI is amended as set out in Annex III to this Regulation.

Correction to Regulation (EC) No 1272/2008

Article 2

Open ↗

Annex VI to Regulation (EC) No 1272/2008 is corrected as set out in Annex IV to this Regulation.

Entry into force and application

Article 3

Open ↗

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union . It shall apply from 1 October 2021. However, Article 2 shall apply from 1 December 2019. Substances and mixtures may, before 1 October 2021, be classified, labelled and packaged in accordance with Regulation (EC) No 1272/2008 as amended by this Regulation. This Regulation shall be binding in its entirety and directly applicable in all Member States.

Supplementary provisions

ANNEX IIISupplementary provisions

Open ↗

ANNEX III Annex VI to Regulation (EC) No 1272/2008 is amended as follows: (1)  Part 1 is amended as follows: (a)  in point 1.1.3.1, the following notes V and W are added: ‘Note V: If the substance is to be placed on the market as fibres (with diameter < 3 μm, length > 5 μm and aspect ratio ≥ 3:1) or particles of the substance fulfilling the WHO fibre criteria or as particles with modified surface chemistry, their hazardous properties must be evaluated in accordance with Title II of this Regulation, to assess whether a higher category (Carc. 1B or 1A) and/or additional routes of exposure (oral or dermal) should be applied.’ ————— (b)  in point 1.1.3.2, the following note 10 is added: ————— (2)  in Part 3, Table 3 is amended as follows: (a)  the rows with index numbers 604-083-00-X and 611-159-00-6 are deleted; (b)  the rows corresponding to index numbers 015-189-00-5, 027-001-00-9, 028-018-00-4, 603-023-00-X, 605-005-00-7, 606-047-00-9, 607-232-00-7, 607-247-00-9, 608-039-00-0, 613-054-00-0, 616-018-00-2 and 648-055-00-5 are replaced by the following rows respectively: Index No Chemical name EC No CAS No Classification Labelling Specific Conc. Limits, M-factors and ATEs Notes Hazard Class and Category Code(s) Hazard statement Code(s) Pictogram, Signal Word Code(s) Hazard statement Code(s) Suppl. Hazard statement Code(s) ‘015-189-00-5 phenyl bis(2,4,6-trimethylbenzoyl)-phosphine oxide 423-340-5 162881-26-7 Skin Sens. 1A Aquatic Chronic 4 H317 H413 GHS07 Wng H317 H413’       ‘027-001-00-9 cobalt 231-158-0 7440-48-4 Carc. 1B Muta. 2 Repr. 1B Resp. Sens. 1 Skin Sens. 1 Aquatic Chronic 4 H350 H341 H360F H334 H317 H413 GHS08 Dgr H350 H341 H360F H334 H317 H413’       ‘028-018-00-4 nickel bis(sulfamidate); nickel sulfamate 237-396-1 13770-89-3 Carc. 1A Muta. 2 Repr. 1B Acute Tox. 4 STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H350i H341 H360D*** H302 H372** H334 H317 H400 H410 GHS08 GHS07 GHS09 Dgr H350i H341 H360D*** H302 H372** H334 H317 H410   oral: ATE = 853 mg/kg bw (anhydrate) oral: ATE = 1098 mg/kg bw (tetrahydrate) STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 % Skin Sens. 1; H317: C ≥ 0,01 % M = 1’   ‘603-023-00-X ethylene oxide; oxirane 200-849-9 75-21-8 Flam. Gas 1 Press. Gas Carc. 1B Muta. 1B Repr. 1B Acute Tox. 3 Acute Tox. 3 STOT SE 3 STOT SE 3 STOT RE 1 Skin Corr. 1 Eye Dam. 1 H220 H350 H340 H360Fd H331 H301 H335 H336 H372 (nervous system) H314 H318 GHS02 GHS08 GHS06 GHS05 Dgr H220 H350 H340 H360Fd H331 H301 H335 H336 H372 (nervous system) H314   inhalation: ATE = 700ppm (gases) oral: ATE = 100 mg/kg bw’ U ‘605-005-00-7 metaldehyde (ISO); 2,4,6,8-tetramethyl-1,3,5,7-tetraoxacyclooctane 203-600-2 108-62-3 Flam. Sol. 2 Repr. 2 Acute Tox. 3 Aquatic Chronic 3 H228 H361f H301 H412 GHS02 GHS08 GHS06 Dgr H228 H361f H301 H412   oral: ATE = 283 mg/kg bw’   ‘606-047-00-9 2-benzyl-2-dimethylamino-4'-morpholinobutyrophenone 404-360-3 119313-12-1 Repr. 1B Aquatic Acute 1 Aquatic Chronic 1 H360D H400 H410 GHS08 GHS09 Dgr H360D H410’       ‘607-232-00-7 pyridate (ISO); O-(6-chloro-3-phenylpyridazin-4-yl) S-octyl thiocarbonate 259-686-7 55512-33-9 Acute Tox. 4 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H302 H315 H317 H400 H410 GHS07 GHS09 Wng H302 H315 H317 H410   oral: ATE = 500 mg/kg bw M = 1 M = 10’   ‘607-247-00-9 dodecyl methacrylate 205-570-6 142-90-5 STOT SE 3 H335 GHS07 Wng H335   STOT SE 3; H335: C ≥ 10 %’   ‘608-039-00-0 2-phenylhexanenitrile 423-460-8 3508-98-3 Acute Tox. 4 Aquatic Chronic 2 H302 H411 GHS07 GHS09 Wng H302 H411   oral: ATE = 500 mg/kg bw’   ‘613-054-00-0 thiabendazole (ISO); 2-(thiazol-4-yl)benzimidazole 205-725-8 148-79-8 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410   M = 1 M = 1’   ‘616-018-00-2 diethyltoluamide (ISO): N,N-diethyl-m-toluamide; [deet] 205-149-7 134-62-3 Acute Tox. 4 Skin Irrit. 2 Eye Irrit. 2 H302 H315 H319 GHS07 Wng H302 H315 H319   oral: ATE = 1892 mg/kg bw’   (c)  the following rows are inserted: Index No Chemical Name EC No CAS No Classification Labelling Specific Conc. Limits, M-factors and ATEs Notes Hazard Class and Category Code(s) Hazard statement Code(s) Pictogram, Signal Word Code(s) Hazard statement Code(s) Suppl. Hazard statement Code(s) ————— 080-012-00-0 methylmercuric chloride 204-064-2 115-09-3 Carc. 2 Repr. 1A Lact. Acute Tox. 2 Acute Tox. 2 Acute Tox. 2 STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 H351 H360Df H362 H330 H310 H300 H372 (nervous system, kidneys) H400 H410 GHS08 GHS06 GHS09 Dgr H351 H360Df H362 H330 H310 H300 H372 (nervous system, kidneys) H410   inhalation: ATE = 0,05 mg/l (dusts or mists) dermal: ATE = 50 mg/kg bw oral: ATE = 5 mg/kg bw 1 ‘601-090-00-X benzo[ rst ]pentaphene 205-877-5 189-55-9 Carc. 1B Muta. 2 H350 H341 GHS08 Dgr H350 H341’       ‘601-091-00-5 dibenzo[ b,def ]chrysene; dibenzo[ a , h ]pyrene 205-878-0 189-64-0 Carc. 1B Muta. 2 H350 H341 GHS08 Dgr H350 H341’       ‘603-236-00-8 ethanol, 2,2’-iminobis-, N -(C13-15-branched and linear alkyl) derivs. 308-208-6 97925-95-6 Repr. 1B H360D GHS08 Dgr H360D’       ‘607-733-00-0 cyflumetofen (ISO); 2-methoxyethyl ( RS )-2-(4- tert -butylphenyl)-2-cyano-3-oxo-3-(α,α,α-trifluoro- o -tolyl)propionate — 400882-07-7 Carc. 2 Skin Sens. 1A H351 H317 GHS08 GHS07 Wng H351 H317’       ‘607-734-00-6 pentapotassium 2,2’,2’’,2’’’,2’’’’-(ethane-1,2-diylnitrilo)pentaacetate 404-290-3 7216-95-7 Acute Tox. 4 STOT RE 2 Eye Irrit. 2 H332 H373 (inhalation) H319 GHS08 GHS07 Dgr H332 H373 (inhalation) H319   inhalation: ATE = 1,5 mg/l (dusts or mists)’   ‘607-735-00-1 N-carboxymethyliminobis(ethylenenitrilo)tetra(acetic acid) 200-652-8 67-43-6 Acute Tox. 4 STOT RE 2 Eye Irrit. 2 H332 H373 (inhalation) H319 GHS08 GHS07 Dgr H332 H373 (inhalation) H319   inhalation: ATE = 1,5 mg/l (dusts or mists)’   ‘607-736-00-7 pentasodium (carboxylatomethyl)iminobis(ethylenenitrilo)tetraacetate 205-391-3 140-01-2 Acute Tox. 4 STOT RE 2 H332 H373 (inhalation) GHS08 GHS07 Dgr H332 H373 (inhalation)   inhalation: ATE = 1,5 mg/l (dusts or mists)’   ‘607-737-00-2 diisohexyl phthalate 276-090-2 71850-09-4 Repr. 1B H360FD GHS08 Dgr H360FD’       ‘608-069-00-4 fludioxonil (ISO); 4-(2,2-difluoro-1,3-benzodioxol-4-yl)-1H-pyrrole-3-carbonitrile — 131341-86-1 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410   M = 1 M = 10’   ‘613-329-00-5 halosulfuron-methyl (ISO); methyl 3-chloro-5-{[(4,6-dimethoxypyrimidin-2-yl)carbamoyl]sulfamoyl}-1-methyl-1H-pyrazole-4-carboxylate — 100784-20-1 Repr. 1B Aquatic Acute 1 Aquatic Chronic 1 H360D H400 H410 GHS08 GHS09 Dgr H360D H410   M = 1000 M = 1000’   613-330-00-0 2-methylimidazole 211-765-7 693-98-1 Repr. 1B H360Df GHS08 Dgr H360Df       ‘616-225-00-8 (RS)-2-methoxy-N-methyl-2-[α-(2,5-xylyloxy)-o-tolyl]acetamide; mandestrobin — 173662-97-0 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410   M = 1 M = 10’   ‘616-226-00-3 carboxin (ISO); 2-methyl-N-phenyl-5,6-dihydro-1,4-oxathiine-3-carboxamide; 5,6-dihydro-2-methyl-1,4-oxathiine-3-carboxanilide 226-031-1 5234-68-4 STOT RE 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H373 (kidneys) H317 H400 H410 GHS08 GHS07 GHS09 Wng H373 (kidneys) H317 H410   M = 1 M = 1’   ‘616-227-00-9 metaflumizone (ISO); ( EZ )-2’-[2-(4-cyanophenyl)-1-(α,α,α -trifluoro-m-tolyl)ethylidene]-[4-(trifluoromethoxy)phenyl]carbanilohydrazide [ E -isomer ≥ 90 %, Z -isomer ≤ 10 % relative content]; [1] ( E )-2’-[2-(4-cyanophenyl)-1-(α,α,α -trifluoro-m-tolyl)ethylidene]-[4-(trifluoromethoxy)phenyl]carbanilohydrazide [2] — 139968-49-3 [1] 852403-68-0 [2] Repr. 2 Lact. STOT RE 2 H361fd H362 H373 GHS08 Wng H361fd H362 H373’       ‘650-056-00-0 dibutylbis(pentane-2,4-dionato-O,O’)tin 245-152-0 22673-19-4 Repr. 1B STOT RE 1 H360FD H372 (immune system) GHS08 Dgr H360FD H372 (immune system)’.

ANNEX IVSupplementary provisions

Open ↗

ANNEX IV In Annex VI to Regulation (EC) No 1272/2008, in table 3, the row with Index No ‘648-055-00-5’ is replaced by the following: Index No Chemical name EC No Cas No Classification Labelling Specific Conc. Limits, M-factors and ATEs Notes Hazard Class and Category Code(s) Hazard statement Code(s) Pictogram, Signal Word Code(s) Hazard statement Code(s) Suppl. Hazard statement Code(s) ‘648-055-00-5 pitch, coal tar, high-temp.; [The residue from the distillation of high temperature coal tar. A black solid with an approximate softening point from 30 °C to 180 °C (86 °F to 356 °F). Composed primarily of a complex mixture of three or more membered condensed ring aromatic hydrocarbons.] 266-028-2 65996-93-2 Carc. 1A Muta. 1B Repr. 1B H350 H340 H360FD GHS08 Dgr H350 H340 H360FD’.

Other acts of the same type
Commission Implementing Regulation (EU) 2023/169 of 25 January 2023 establishing the template for the annual performance reports on the Asylum, Migration and Integration Fund for the 2021-2027 programming period, pursuant to Regulation (EU) 2021/1147 of the European Parliament and of the CouncilCommission Implementing Regulation (EU) 2023/170 of 25 January 2023 establishing the template for the annual performance reports on the Internal Security Fund for the 2021-2027 programming period, pursuant to Regulation (EU) 2021/1149 of the European Parliament and of the CouncilCommission Implementing Regulation (EU) 2023/197 of 24 January 2023 approving non-minor amendments to the product specification for a name entered in the register of protected designations of origin and protected geographical indications (‘Steirisches Kürbiskernöl’ (PGI))Commission Delegated Regulation (EU) 2023/1090 of 24 January 2023 amending Regulation (EU) 2019/833 of the European Parliament and of the Council, and Commission Delegated Regulation (EU) 2020/124 as regards certain provisions of the conservation and enforcement measures of the Northwest Atlantic Fisheries Organisation (NAFO)Council Implementing Regulation (EU) 2023/152 of 23 January 2023 implementing Regulation (EU) No 359/2011 concerning restrictive measures directed against certain persons, entities and bodies in view of the situation in IranCouncil Regulation (EU) 2023/154 of 23 January 2023 amending Regulation (EC) No 147/2003 concerning certain restrictive measures in respect of SomaliaCouncil Regulation (EU) 2023/155 of 23 January 2023 amending Regulation (EU) No 356/2010 imposing certain specific restrictive measures directed against certain natural or legal persons, entities or bodies, in view of the situation in SomaliaCouncil Implementing Regulation (EU) 2023/156 of 23 January 2023 implementing Regulation (EU) No 101/2011 concerning restrictive measures directed against certain persons, entities and bodies in view of the situation in TunisiaCommission Implementing Regulation (EU) 2023/157 of 23 January 2023 amending Implementing Regulation (EU) 2021/2266 as regards the reference to the certificate and the self-certification of independent small producers of alcoholic beverages in the electronic simplified administrative documentCommission Implementing Regulation (EU) 2023/158 of 23 January 2023 amending Implementing Regulation (EU) 2018/2019 as regards certain plants for planting of Prunus domestica and Prunus cerasifera originating in UkraineCommission Implementing Regulation (EU) 2023/184 of 23 January 2023 entering a name in the register of protected designations of origin and protected geographical indications (‘Ciliegia di Bracigliano’ (PGI))Commission Regulation (EU) 2023/147 of 20 January 2023 amending Annexes II, III and V to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for cyromazine, topramezone and triflumizole in or on certain products (Text with EEA relevance)

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

Contents

What to look at next